Incretin-Based Therapy: A Powerful and Promising Weapon in the Treatment of Type 2 Diabetes Mellitus

Diabetes Therapy - United States
doi 10.1007/s13300-011-0002-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Insulinization: A Promising Strategy for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Comparison of Efficacy Between Incretin-Based Therapies for Type 2 Diabetes Mellitus

BMC Medicine
Medicine
2012English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2007English

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes

Vascular Health and Risk Management
PharmacologyCardiologyEndocrinologyPublic HealthHematologyEnvironmentalCardiovascular MedicineMedicineOccupational HealthMetabolismDiabetes
2006English

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy